LAS VEGAS -- Implementing a substance use screening program for pregnant patients admitted for delivery was associated with a ...

Three drugs that inhibit the immunoglobulin G (IgG) neonatal fragment crystallizable receptor (FcRn) were approved to treat ...

In " Beyond Diagnosis: Breast Cancer," Cleveland Clinic oncologist Tiffany Onger, MD, and host John Mangels continue their ...

Solriamfetol (Sunosi), a selective dopamine and norepinephrine reuptake inhibitor, improved sleepiness compared with placebo ...

Rheumatoid arthritis (RA) patients face increased risk for interstitial lung disease (ILD) that is worsened further by the ...

The word "influenza" originally stemmed from the medieval Latin influentia at a time when fluids emanating from heavenly ...

In the U.S., an estimated one in 31 children have autism spectrum disorder. Researchers estimate around a quarter have "profound autism," a term introduced in 2021 by a group of experts, the Lancet ...

BridgeBio Pharma's infigratinib, an investigational drug that addresses the underlying cause of achondroplasia, significantly improved annualized height velocity in children with open growth plates ...

Every day, we seem to be inundated with more and more innovations and new technologies, whizbang cool devices, software, and blood tests. It's getting easier and easier to test and detect more and ...

The FDA has approved the topical phosphodiesterase 4 (PDE4) inhibitor difamilast (Adquey) as a new option for mild/moderate atopic dermatitis (AD).

Now, CMS' Innovation Center, which created Making Care Primary, is set to launch a new 10-year program to boost primary care called the Long-term Enhanced ACO Design, known by its acronym LEAD. In ...

As I type this, I am fighting back my own tears. Our reality is heartbreaking. But my tears are also filled with something else: frustration. Frustration that once again, medicine and science seem to ...